Showing results (2161-2170 of 2,809) with videos related to

Sort By:
Pageof 281
Cytotherapy|May 16, 2006
Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transportV Antonenas, F Garvin, M Webb, et al.
Cytotherapy|June 9, 2020
Adipose tissue and the vascularization of biomaterials: Stem cells, microvascular fragments and nanofat-a reviewPranitha Kamat, Florian S Frueh, Michelle McLuckie, et al.
Cytotherapy|June 24, 2020
Porcine acellular dermal matrix accelerates wound healing through miR-124-3p.1 and miR-139-5pXiaodong Chen, Ronghua Yang, Jingru Wang, et al.
Cytotherapy|June 18, 2020
Transfer of antigen-encoding bone marrow under immune-preserving conditions deletes mature antigen-specific B cells in recipients and inhibits antigen-specific antibody productionJeremy F Brooks, James E M Barber, Janet M Davies, et al.
Cytotherapy|June 12, 2020
Mapping human serum-induced gene networks as a basis for the creation of biomimetic periosteum for bone repairRawiya Al Hosni, Mittal Shah, Umber Cheema, et al.
Cytotherapy|May 27, 2020
Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to selfSusanne Michen, Jennifer Frosch, Monika Füssel, et al.
Cytotherapy|May 23, 2020
Derivation of clinical-grade mesenchymal stromal cells from umbilical cord under chemically defined culture condition - platform for future clinical applicationXiaoyun Wu, Zhijie Ma, Daocheng Wu
Cytotherapy|May 17, 2020
What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costingsRenske M T Ten Ham, Anke M Hövels, Jarno Hoekman, et al.
Cytotherapy|September 20, 2021
Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?Katie Palen, Joanna Zurko, Bryon D Johnson, et al.
Cytotherapy|September 20, 2021
BL-01, an Fc-bearing, tetravalent CD20 × CD5 bispecific antibody, redirects multiple immune cells to kill tumors in vitro and in vivoAntonella Interdonato, Sylvie Choblet, Mirco Sana, et al.
Pageof 281